Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics.
Takeshi OsonoiShinya NakamotoMiyoko SaitoAtsuko TamasawaHidenori IshidaYusuke OsonoiPublished in: Journal of diabetes investigation (2017)
Ipragliflozin is a useful oral antidiabetic medication for patients with a wide range of background characteristics.